Article

Reporting Practices for Secondary Findings among ERN GENTURIS Member Institutions in 15 European Countries

2025-09-11

Abstract excerpt

<title>Abstract</title> <p>Secondary findings (SF) identified in massive parallel sequencing raise important clinical and healthcare related questions. To get an overview on current practices of European healthcare providers (HCP), we conducted a cross-sectional survey study among 39 stakeholders —predominantly senior medical and laboratory geneticists — from 15 European countries participating in the European Re...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9f8a4863-b80e-5a93-b97e-3be2bf47ad8a
DOI: 10.21203/rs.3.rs-7317728/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Reporting Practices for Secondary Findings among ERN GENTURIS Member Institutions in 15 European CountriesDOI 10.21203/rs.3.rs-7317728/v1Read

The European Reference Network on Genetic Tumour Risk Syndromes (ERN GENTURIS): benefits for patients, families, and health care providers.Semantic proximity Read

A comprehensive genomic reporting structure for communicating all clinically significant primary and secondary findingsSemantic proximity Read

Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and GenomicsSemantic proximity Read

Secondary findings after multi-gene panel testing in 7,388 patients with suspected cancer predisposition syndrome.Semantic proximity Read

ACMG Secondary Findings in the Brazilian Rare Genomes Project: Insights from 5,402 genome sequencingSemantic proximity Read

ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG)Semantic proximity Read

ACMG SF v3.3 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG)Semantic proximity Read

Guidelines for diagnostic next-generation sequencingSemantic proximity Read

ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG)Semantic proximity Read

ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG)Semantic proximity Read

Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG)Semantic proximity Read

ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencingSemantic proximity Read